Objectives
AVANT is a multi-actor inter-sectorial project aimed at developing alternatives to antimicrobials for the management of bacterial infections in pigs, especially diarrhoea during the weaning period, as the major indication for antimicrobial use in livestock in Europe. During pre-clinical studies, efficacy, toxicity, and mode of action of these interventions is tested, and their dosage and formulation optimized. The results and a survey for veterinarian-, farmer- and consumers perception of antimicrobial alternatives, will be used together with legal and economic considerations to select three interventions for large-scale farm trials, assessing clinical efficacy and impact on antimicrobial use.
Objectives
AVANT is a multi-actor inter-sectorial project aimed at developing alternatives to antimicrobials for the management of bacterial infections in pigs, especially diarrhoea during the weaning period, as the major indication for antimicrobial use in livestock in Europe. During pre-clinical studies, efficacy, toxicity, and mode of action of these interventions is tested, and their dosage and formulation optimized. The results and a survey for veterinarian-, farmer- and consumers perception of antimicrobial alternatives, will be used together with legal and economic considerations to select three interventions for large-scale farm trials, assessing clinical efficacy and impact on antimicrobial use.
Activities
The AVANT portfolio comprises a variety of alternatives for treatment or prevention of diarrhoea and/or respiratory infections, namely:
• Gut-stabilizing interventions based on a symbiotic (pre- and probiotic) product and faecal microbiota transplantation
• Novel veterinary medicinal products containing bacteriophages and polymers for targeted treatment of enterotoxigenic E. coli infections
• Immuno-stimulating injectable and feed additive products
• Alternative feeding strategies targeting sows and piglets
All steps are supported by regulatory advice for quick market entry post-project. Generated and existing data on antimicrobial use, pig demographics and projected consumption of pork, will be used in mathematical modelling to estimate the reduction in antimicrobial use that could be achieved by 2030, if the AVANT alternatives were widely adopted in pig production.
Additional information
AVANT has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 862829.
Project details
- Main funding source
- Horizon 2020 (EU Research and Innovation Programme)
- Project acronym
- AVANT
- Agricultural sectors
-
- Livestock (generic)
- Pigs
€ € 6 537 033,75
Total budget
Total contributions including EU funding.
€ € 5 999 905,02
EU contribution
Any type of EU funding.
Project keyword
Contacts
Stefan Weiss
Project coordinator
-
University of Copenhagen
Project coordinator
Project partners
-
Biomin
Project partner
-
Cooperl
Project partner
-
Easy-Agricare
Project partner
-
Federation of Veterinarians of Europe
Project partner
-
Klifovet
Project partner
-
Ovejero Laboratories
Project partner
-
Royal Veterinary College
Project partner
-
RTDS Group
Project partner
-
Schothorst Feed Research
Project partner
-
Danish Agriculture & Food Council F.m.b.A. SEGES
Project partner
-
Swiss Federal Institute of Technology, Zurich
Project partner
-
Universidad Complutense de Madrid
Project partner
-
Wageningen Research
Project partner